Komori
Kaken Pharmaceutical (4521) · InitiativeRestated

Changing the Depreciation Method for Property, Plant and Equipment to the Straight-Line Method

First written in FY2017-Q2. 4 of 5 entries say "Restated". Latest entry: FY2022.

5entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q2 – FY20222016: 12017: 120172018: 120182019: 120192020: 020202021: 020212022: 12022
Same theme, other companies
Change in depreciation method based on expected stability in production volumes and operating ratesA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「Property, plant and equipment Straight-line method」

    The straight-line method continues to be used for depreciating property, plant and equipment.
  2. FY2019RestatedAnnual report

    「Property, plant and equipment Straight-line method」

    The straight-line method continues to be used for depreciating property, plant and equipment.
  3. FY2018RestatedAnnual report

    「Property, plant and equipment Straight-line method」

    The annual accounting policies also confirm that the straight-line method is used to depreciate property, plant and equipment.
  4. FY2017-Q3RestatedAnnual report

    「The Company had primarily used the declining-balance method to depreciate property, plant and equipment, but changed to the straight-line method from the first quarter of the fiscal year.」

    The change in accounting policy from primarily the declining-balance method to the straight-line method from the first quarter of the fiscal year has been reaffirmed, along with the details and reasons for the change.
  5. FY2017-Q2First statedAnnual report

    「The Company had primarily used the declining-balance method to depreciate property, plant and equipment, but changed to the straight-line method from the first quarter of the fiscal year.」

    From the first quarter of the fiscal year, the depreciation method was changed primarily from the declining-balance method to the straight-line method. The Company explained that production volumes, operating rates and other factors are expected to remain stable over the long term, and that the change would more appropriately reflect the actual use of the equipment.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Kaken Pharmaceutical's next results are scheduled for 2026-11-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.